1)Kokubo Y, et al:Accumulation of neurofilaments and SOD1-immunoreactive products in a patient with familial amyotrophic lateral sclerosis with I113T SOD1 mutation. Arch Neurol 56:1506-1508, 1999
2)Andersen PM, Al-Chalabi A:Clinical genetics of amyotrophic lateral sclerosis;What do we really know? Nat Rev Neurol 7:603-615, 2011
3)Byrne S, et al:Rate of familial amyotrophic lateral sclerosis;A systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 82:623-627, 2011
4)「特定疾患患者の自立支援体制の確立に関する研究」班:「筋萎縮性側索硬化症患者の意向の尊重とケア(事前指示)に関する検討」中間報告書,2011
5)Narita Y, et al:End of life self-determination;Attitudes of patients with ALS in a prefecture of Japan. Eubios J Asian Int Bioeth 18:66-70, 2008
6)Chio A, et al:Conjugal amyotrophic lateral sclerosis;Suggestion for the implication of environmental factors. Amyotroph Lateral Scler Other Motor Neuron Disord 2:165-166, 2001
7)Tsai CP, et al:A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan. Neurobiol Aging 33:2232, 2012